Try our Advanced Search for more refined results

INSULIN PRICING LITIGATION Assigned to: Judge Brian R. Martinotti Referred to: Magistrate Judge Rukhsanah L. Singh Cause: 18:1962 Racketeering (RICO) Act

Track this case

Case overview

Case Number:

2:23-md-03080

Court:

New Jersey

Nature of Suit:

470 Racketeer/Corrupt Organization

Multi Party Litigation:

Multi-district Litigation

Judge:

Judge Brian R. Martinotti

Firms

Companies

Government Agencies

Sectors & Industries:

  1. January 02, 2025

    1st Private Co. Joins Insulin Price-Fixing MDL

    A Florida-based car dealer is the first private company to join a multidistrict litigation accusing Novo Nordisk, Eli Lilly and Sanofi-Aventis of fixing the prices of insulin and other drugs to treat diabetes.

  2. June 10, 2024

    Drugmakers Look To Nix Non-Insulin Claims From AG Suit

    Novo Nordisk, Eli Lilly and Sanofi-Aventis asked the federal judge overseeing a diabetes drug price-fixing multidistrict litigation to rule for drugmakers on Mississippi's claims the pricing for GLP-1s is illegal, saying in a brief that the drugs are under patent and too new to be included in the insulin-pricing suit.

  3. February 08, 2024

    Mich. Counties Sue Drug Giants Over Insulin Prices

    Several Michigan counties on Wednesday accused some of the world's largest drugmakers, retailers and pharmacy benefit managers of scheming to inflate insulin prices and costing the municipalities millions of extra dollars in healthcare costs for their employees and retirees.

  4. December 06, 2023

    Judge Orders 3 Case Tracks, Appoints Counsel In Insulin MDL

    A New Jersey federal judge on Wednesday established three tracks for cases to follow in the multidistrict litigation that accuses drugmakers and pharmacy benefit managers of illegally inflating the price of insulin.

  5. November 29, 2023

    Drug Giants Face 3rd RICO Suit In 3 Weeks Over Insulin Prices

    A Maryland county south of Washington, D.C., has joined the flood of litigation accusing drugmakers and pharmacy benefit managers of violating a federal racketeering law in a scheme to jack up insulin prices.

  6. November 21, 2023

    Drug Giants Face New Racketeering Suit Over Insulin Prices

    A second Virginia county in two weeks has sued Eli Lilly and others under a federal racketeering law, alleging drugmakers and pharmacy benefit managers illegally schemed to limit competition and artificially inflate the price of insulin drugs.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!